1. Just Say No: The Case Against Opioid-Based Postoperative Pain Management Regimens Following Breast Surgery

   • Theresa Schwartz

   Breast Oncology 03 April 2021 Pages: 5799 - 5800

2. The Surgeons’ Role When Systemic Therapies Fail in Metastatic Melanoma: The Salvage Metastasectomy

   • Jonathan S. Zager

   Melanoma 21 July 2021 Pages: 5801 - 5802

3. Lateral Pelvic Node Metastasis in Locally Advanced Rectal Cancer: Are We Exaggerating or Ignoring?

   • Gyu-Seog Choi

   Colorectal Cancer 11 August 2021 Pages: 5803 - 5804

4. Time to Evolve Terminology from “Debulking” to Cytoreductive Surgery (CRS) in Ovarian Cancer

   • Donal J. Brennan
   • Brendan J. Moran

   Gynecologic Oncology 24 July 2021 Pages: 5805 - 5807

5. Thumbprinting Locally Advanced Pancreatic Cancer: Have We Developed the Optimal Staging System?

   • Caitlin A. Hester
   • Matthew H. G. Katz

   Pancreatic Tumors 21 May 2021 Pages: 5808 - 5810

6. Further Consideration of Lymphadenectomy Along the Left Recurrent Laryngeal Nerve During Robot-Assisted Minimally Invasive Esophagectomy

   • Kazuto Harada
   • Masaaki Iwatsuki
   • Hideo Baba

   Thoracic Oncology 17 July 2021 Pages: 5811 - 5812

7. Minimally Invasive Esophagectomy: Are We There Yet?

   • Zane Hammoud

   Thoracic Oncology 23 June 2021 Pages: 5813 - 5814

8. Postoperative Regional Analgesia Options Following Esophageal Surgery

   • Pete L. Pelletier
   • Margaret E. Griesemer

   Thoracic Oncology 26 May 2021 Pages: 5815 - 5817

9. Editorial Comment to “A nomogram Based on a Collagen Feature Support Vector Machine for Predicting the Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients”

   • Akiko Yashima-Abo
   • Koki Otsuka
   • Satoshi S. Nishizuka

   Translational Research 24 June 2021 Pages: 5818 - 5819

10. John Wayne Clinical Research Lecture: New Avenues for Uplifting the Global Quality of Care in Surgical Oncology

    • Jatin P. Shah

    Head and Neck Oncology 17 June 2021 Pages: 5820 - 5828

    

11. Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study

    • Konstantin S. Leppelmann
    • Vincent M. Levesque
    • Florian J. Fintelmann

    Head and Neck Oncology 23 February 2021 Pages: 5829 - 5839

    

12. ASO Author Reflections: Percutaneous Image-Guided Ablation and Multi-modality Management of Lung Metastases

    • Konstantin S. Leppelmann
    • Florian J. Fintelmann

    ASO Author Reflections 04 March 2021 Pages: 5840 - 5841

13. Contribution of Genomics to the Surgical Management and Study of Oral Cancer

    • Zuzana Saidak
    • Claire Lailler
    • Antoine Galmiche

    Head and Neck Oncology Open access 12 April 2021 Pages: 5842 - 5854

    

14. Opioid-Sparing Multimodal Analgesia Protocol for Lumpectomy Patients Results in Superior Postoperative Pain Control

    • Claudya Morin
    • Yamini Patel
    • Kristin E. Rojas

    Breast Oncology 02 June 2021 Pages: 5855 - 5864

    

15. ASO Author Reflections: The Time to Incorporate Opioid-Minimizing Initiatives in Your Institution is now

    • Claudya Morin
    • Patrick I. Borgen
    • Kristin E. Rojas

    ASO Author Reflections 20 April 2021 Pages: 5865 - 5866

16. Changes in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer Database (NCDB)

    • Rita A. Mukhtar
    • Tanya L. Hoskin
    • Judy C. Boughey

    Breast Oncology Open access 09 March 2021 Pages: 5867 - 5877

    

17. ASO Author Reflections: Changes in Primary Treatment Strategy for Invasive Lobular Carcinoma Highlight the Need for Better Predictors of Therapy Response

    • Rita A. Mukhtar
    • Judy C. Boughey

    ASO Author Reflections 11 March 2021 Pages: 5878 - 5879

18. A Phase II Trial of Once Weekly Hypofractionated Breast Irradiation for Early Stage Breast Cancer

    • Harriet Eldredge-Hindy
    • Jianmin Pan
    • Nicolas Ajkay

    Breast Oncology 18 March 2021 Pages: 5880 - 5892

    

19. ASO Author Reflections: Five-Fraction Whole-Breast Radiation: Let’s Make Adjuvant Therapy Accessible

    • Harriet Eldredge-Hindy

    ASO Author Reflections 11 March 2021 Pages: 5893 - 5894

20. Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma

    • Natalie Hills
    • Macall Leslie
    • Takemi Tanaka

    Breast Oncology Open access 21 March 2021 Pages: 5895 - 5905

    

21. ASO Author Reflections: Does Prompt Breast-Conserving Surgery Matter?

    • Natalie Hills
    • Macall Leslie
    • Takemi Tanaka

    ASO Author Reflections 05 March 2021 Pages: 5906 - 5906

22. Alterations in Breast Cancer Biomarkers Following Neoadjuvant Therapy

    • Srivarshini Cherukupalli Mohan
    • Sarah Walcott-Sapp
    • Alice P. Chung

    Breast Oncology 21 March 2021 Pages: 5907 - 5917

    

23. ASO Author Reflections: Biomarker Changes After Neoadjuvant Therapy: Do They Matter?

    • Srivarshini Cherukupalli Mohan
    • Alice Chung

    ASO Author Reflections 31 March 2021 Pages: 5918 - 5919

24. Oncological Safety of Oncoplastic Level II Mammoplasties After Neoadjuvant Chemotherapy for Large Breast Cancers: A Matched-Cohort Analysis

    • Raquel F. D. van la Parra
    • Krishna B. Clough
    • Claude Nos

    Breast Oncology 28 March 2021 Pages: 5920 - 5928

    

25. The Impact of Preoperative Breast MRI on Surgical Margin Status in Breast Cancer Patients Recalled at Biennial Screening Mammography: An Observational Cohort Study

    • Jessie J. J. Gommers
    • Lucien E. M. Duijm
    • Adri C. Voogd

    Breast Oncology Open access 01 April 2021 Pages: 5929 - 5938

    

26. ASO Author Reflections: Impact of Preoperative MRI on Patients With Screen-Detected Invasive Breast Cancer Undergoing Breast-Conserving Surgery

    • Jessie J. J. Gommers
    • Lucien E. M. Duijm
    • Adri C. Voogd

    ASO Author Reflections Open access 11 April 2021 Pages: 5939 - 5940

27. Association of Insulin Resistance and Higher Oncotype DX™ Recurrence Score

    • Nicole T. Gordon
    • Jaime J. Alberty-Oller
    • Nina A. Bickell

    Breast Oncology 03 April 2021 Pages: 5941 - 5947

28. Genomic Assays and the Great Unknown: The Oncotype DX™ May Miss the Mark in Certain Populations

    • Nicole Gordon
    • J. Alberty-Oller

    ASO Author Reflections 04 April 2021 Pages: 5948 - 5949

29. Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone Therapy

    • Elaine McKevitt
    • Rona Cheifetz
    • Alan Nichol

    Breast Oncology 05 April 2021 Pages: 5950 - 5957

    

30. ASO Author Reflections: Selective Nodal Staging and De-escalating Adjuvant Therapy

    • Elaine McKevitt
    • Alan Nichol

    ASO Author Reflections 14 April 2021 Pages: 5958 - 5959

31. Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance)

    • Anna Weiss
    • Jordan Campbell
    • Mehra Golshan

    Breast Oncology 05 April 2021 Pages: 5960 - 5971

    

32. ASO Author Reflections: Accurately Predicting Nodal pCR Holds the Key to Axillary Surgery De-escalation Strategies

    • Anna Weiss
    • Mehra Golshan
    • David W. Ollila

    ASO Author Reflections 13 April 2021 Pages: 5972 - 5973

33. The Clinical Utility of DCISionRT^® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery

    • Chirag Shah
    • Troy Bremer
    • Frank A. Vicini

    Breast Oncology Open access 05 April 2021 Pages: 5974 - 5984

    

34. Longitudinal Study of Psychosocial Outcomes Following Surgery in Women with Unilateral Nonhereditary Breast Cancer

    • David W. Lim
    • Helene Retrouvey
    • Kelly A. Metcalfe

    Breast Oncology 05 April 2021 Pages: 5985 - 5998

    

35. ASO Author Reflections: Psychosocial Outcomes After Breast Cancer Treatment

    • David W. Lim
    • Kelly A. Metcalfe

    ASO Author Reflections 05 May 2021 Pages: 5999 - 6000

36. Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer

    • Lifen Cao
    • Jonathan J. Hue
    • Megan E. Miller

    Breast Oncology 06 April 2021 Pages: 6001 - 6011

    

37. Addressing Gender Disparity in Breast Cancer Care

    • Lifen Cao
    • Jonathan J. Hue
    • Megan E. Miller

    ASO Author Reflections 28 April 2021 Pages: 6012 - 6013

38. Evaluation of the AJCC Eighth-Edition Prognostic Staging System for Breast Cancer in a Latin American Cohort

    • Sergio Cervera-Bonilla
    • Paola Rodríguez-Ossa
    • Sandra Diaz-Casas

    Breast Oncology 08 April 2021 Pages: 6014 - 6021

    

39. ASO Author Reflections: Evaluation of the 8th AJCC Prognostic Staging System for Breast Cancer in a Latin American Cohort

    • Sergio Cervera-Bonilla
    • Luis Guzmán-Abisaab
    • Paola Rodríguez-Ossa

    ASO Author Reflections 09 April 2021 Pages: 6022 - 6023

40. Tumor-Nipple Distance of ≥ 1 cm Predicts Negative Nipple Pathology After Neoadjuvant Chemotherapy

    • Tracy-Ann Moo
    • Carolina Rossi Saccarelli
    • Virgilio Sacchini

    Breast Oncology 17 April 2021 Pages: 6024 - 6029

    

41. ASO Author Reflections: Tumor-Nipple Distance of ≥ 1 cm on Pre- or Post-Neoadjuvant Chemotherapy Imaging can be used to Determine Eligibility for Nipple-Sparing Mastectomy

    • Tracy-Ann Moo
    • Virgilio Sacchini

    ASO Author Reflections 16 April 2021 Pages: 6030 - 6031

42. Intraductal Papilloma of the Breast: Prevalence of Malignancy and Natural History Under Active Surveillance

    • Jessica Limberg
    • Whitney Kucher
    • Jennifer L. Marti

    Breast Oncology 19 April 2021 Pages: 6032 - 6040

    

43. ASO Author Reflections: A Plea Against Blind Fear of Benign ‘High-Risk’ Lesions of the Breast: Five Recommendations to Minimize Unnecessary Treatment

    • Jennifer L. Marti

    ASO Author Reflections 19 April 2021 Pages: 6041 - 6043

44. Is Residual Nodal Disease at Axillary Dissection Associated with Tumor Subtype in Patients with Low Volume Sentinel Node Metastasis After Neoadjuvant Chemotherapy?

    • Tracy-Ann Moo
    • Kate R. Pawloski
    • Monica Morrow

    Breast Oncology 19 April 2021 Pages: 6044 - 6050

    

45. Burnout and Professional Fulfillment in Early and Early-Mid-Career Breast Surgeons

    • Jennifer Q. Zhang
    • Joe Dong
    • Ted James

    Breast Oncology 19 April 2021 Pages: 6051 - 6057

46. ASO Author Reflections: Revisiting the Role of Induction Chemotherapy Plus Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Junction Adenocarcinoma

    • Robert J. Torphy
    • Felix Ho
    • Martin D. McCarter

    ASO Author Reflections 17 April 2021 Pages: 6058 - 6059

47. Palpable Adenopathy Does Not Indicate High-Volume Axillary Nodal Disease in Hormone Receptor-Positive Breast Cancer

    • Angelena Crown
    • Varadan Sevilimedu
    • Monica Morrow

    Breast Oncology 19 April 2021 Pages: 6060 - 6068

48. ASO Author Reflections: Rethinking Palpable Adenopathy as a Marker of High-Volume Axillary Nodal Disease in Hormone Receptor-Positive Breast Cancer

    • Angelena Crown
    • Monica Morrow

    ASO Author Reflections 19 April 2021 Pages: 6069 - 6070

49. Arm Morbidity After Local Therapy for Young Breast Cancer Patients

    • Anne Kuijer
    • Laura S. Dominici
    • Tari A. King

    Breast Oncology 21 April 2021 Pages: 6071 - 6082

    

50. Ductal Carcinoma in Situ in Young Women: Increasing Rates of Mastectomy and Variability in Endocrine Therapy Use

    • David J. Byun
    • S. Peter Wu
    • Naamit K. Gerber

    Breast Oncology 29 April 2021 Pages: 6083 - 6096